Connect Biopharma Holdings Ltd is trading at $2.40 (13.3%) in pre-market today, gaining momentum despite a lack of company-specific news or regulatory updates.
- The sharp move occurs in the absence of fresh headlines, earnings reports, FDA updates, or major analyst calls tied to the stock.
- The advance appears to be driven by a broader risk-on tone in U.S. equity futures, which are all trading more than 1% higher, suggesting market sentiment is the primary catalyst.